Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 2 |
2007 | 1 |
2008 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.
Eur J Clin Pharmacol. 2008 May;64(5):511-9. doi: 10.1007/s00228-007-0456-4. Epub 2008 Jan 16.
Eur J Clin Pharmacol. 2008.
PMID: 18197403
Clinical Trial.
Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions.
Karjalainen MJ, Neuvonen PJ, Backman JT.
Karjalainen MJ, et al.
Drug Metab Dispos. 2006 Dec;34(12):2091-6. doi: 10.1124/dmd.106.011965. Epub 2006 Sep 19.
Drug Metab Dispos. 2006.
PMID: 16985100
Item in Clipboard
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
Backman JT, Karjalainen MJ, Neuvonen M, Laitila J, Neuvonen PJ.
Backman JT, et al. Among authors: karjalainen mj.
Br J Clin Pharmacol. 2006 Sep;62(3):345-57. doi: 10.1111/j.1365-2125.2006.02653.x.
Br J Clin Pharmacol. 2006.
PMID: 16934051
Free PMC article.
Clinical Trial.
Item in Clipboard
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.
Karjalainen MJ, Neuvonen PJ, Backman JT.
Karjalainen MJ, et al.
Eur J Clin Pharmacol. 2007 Sep;63(9):829-36. doi: 10.1007/s00228-007-0335-z. Epub 2007 Jul 6.
Eur J Clin Pharmacol. 2007.
PMID: 17618427
Clinical Trial.
Item in Clipboard
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions.
Karjalainen MJ, Neuvonen PJ, Backman JT.
Karjalainen MJ, et al.
Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):157-65. doi: 10.1111/j.1742-7843.2008.00252.x.
Basic Clin Pharmacol Toxicol. 2008.
PMID: 18816299
Free article.
Item in Clipboard
Cite
Cite